EP2351589A1 — Devices for glaucoma treatment
Assigned to Glaukos Corp · Expires 2011-08-03 · 15y expired
What this patent protects
Intraocular stents (229) and applicators are disclosed for treating glaucoma. The stents (229) are configured to extend between the anterior chamber of the eye and Schlemm's canal (22) for enhancing outflow of aqueous from the anterior chamber (20) so as to reduce intraocular pre…
USPTO Abstract
Intraocular stents (229) and applicators are disclosed for treating glaucoma. The stents (229) are configured to extend between the anterior chamber of the eye and Schlemm's canal (22) for enhancing outflow of aqueous from the anterior chamber (20) so as to reduce intraocular pressure. The stents (229) can have features for anchoring the stent into Schlemm's canal (22) as well as preventing the walls of Schlemm's canal (22) from closing the outlet of the stents (229). The applicators can be steerable so as to make implantation easier. Additionally, the applicators can be configured to hold a plurality of stents so that multiple stents can be implanted through one incision without removing the applicator from the incision between serial implantations.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.